 | • レポートコード：GIR201104128 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、末期腎疾患（ESRD）用治療薬の世界市場を調査対象にし、末期腎疾患（ESRD）用治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドルマブ、その他）、用途別分析（病院、クリニック、ICU、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：CTI BioPharma Corp、Prolong Pharmaceuticals LLC、Merck & Co Inc、Novartis AG、VESSL Therapeutics Ltd ・メーカー別販売量、売上、市場シェア ・末期腎疾患（ESRD）用治療薬の地域別市場分析 ・末期腎疾患（ESRD）用治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・末期腎疾患（ESRD）用治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・末期腎疾患（ESRD）用治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・末期腎疾患（ESRD）用治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・末期腎疾患（ESRD）用治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・末期腎疾患（ESRD）用治療薬の種類別市場規模2015-2020：コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドルマブ、その他 ・末期腎疾患（ESRD）用治療薬の用途別市場規模2015-2020：病院、クリニック、ICU、その他 ・末期腎疾患（ESRD）用治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global End-Stage Renal Disease (ESRD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The End-Stage Renal Disease (ESRD) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
End-Stage Renal Disease (ESRD) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, End-Stage Renal Disease (ESRD) Drugs market has been segmented into
Calcium Succinate
Mk-3866
Pacritinib
Sanguinate
Tesidolumab
Others
By Application, End-Stage Renal Disease (ESRD) Drugs has been segmented into:
Hospital
Clinic
ICU
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global End-Stage Renal Disease (ESRD) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level End-Stage Renal Disease (ESRD) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global End-Stage Renal Disease (ESRD) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the End-Stage Renal Disease (ESRD) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and End-Stage Renal Disease (ESRD) Drugs Market Share Analysis
End-Stage Renal Disease (ESRD) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, End-Stage Renal Disease (ESRD) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the End-Stage Renal Disease (ESRD) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in End-Stage Renal Disease (ESRD) Drugs are:
CTI BioPharma Corp
Prolong Pharmaceuticals LLC
Merck & Co Inc
Novartis AG
VESSL Therapeutics Ltd
Among other players domestic and global, End-Stage Renal Disease (ESRD) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe End-Stage Renal Disease (ESRD) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of End-Stage Renal Disease (ESRD) Drugs, with price, sales, revenue and global market share of End-Stage Renal Disease (ESRD) Drugs in 2018 and 2019.
Chapter 3, the End-Stage Renal Disease (ESRD) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the End-Stage Renal Disease (ESRD) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, End-Stage Renal Disease (ESRD) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe End-Stage Renal Disease (ESRD) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 End-Stage Renal Disease (ESRD) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Calcium Succinate
1.2.3 Mk-3866
1.2.4 Pacritinib
1.2.5 Sanguinate
1.2.6 Tesidolumab
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ICU
1.3.5 Others
1.4 Overview of Global End-Stage Renal Disease (ESRD) Drugs Market
1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CTI BioPharma Corp
2.1.1 CTI BioPharma Corp Details
2.1.2 CTI BioPharma Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CTI BioPharma Corp SWOT Analysis
2.1.4 CTI BioPharma Corp Product and Services
2.1.5 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Prolong Pharmaceuticals LLC
2.2.1 Prolong Pharmaceuticals LLC Details
2.2.2 Prolong Pharmaceuticals LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Prolong Pharmaceuticals LLC SWOT Analysis
2.2.4 Prolong Pharmaceuticals LLC Product and Services
2.2.5 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck & Co Inc
2.3.1 Merck & Co Inc Details
2.3.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck & Co Inc SWOT Analysis
2.3.4 Merck & Co Inc Product and Services
2.3.5 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 VESSL Therapeutics Ltd
2.5.1 VESSL Therapeutics Ltd Details
2.5.2 VESSL Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 VESSL Therapeutics Ltd SWOT Analysis
2.5.4 VESSL Therapeutics Ltd Product and Services
2.5.5 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 End-Stage Renal Disease (ESRD) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 End-Stage Renal Disease (ESRD) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
4.5 South America End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
6.3 UK End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
6.4 France End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
7.5 India End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global End-Stage Renal Disease (ESRD) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2015-2020)
11 Global End-Stage Renal Disease (ESRD) Drugs Market Segment by Application
11.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
11.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025)
12.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025)
12.2.4 South America End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025)
12.3 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Type (2021-2025)
12.4 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global End-Stage Renal Disease (ESRD) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of End-Stage Renal Disease (ESRD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global End-Stage Renal Disease (ESRD) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. CTI BioPharma Corp Basic Information, Manufacturing Base and Competitors
Table 8. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Major Business
Table 9. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Total Revenue (USD Million) (2018-2019)
Table 10. CTI BioPharma Corp SWOT Analysis
Table 11. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product and Services
Table 12. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Prolong Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 14. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Major Business
Table 15. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Prolong Pharmaceuticals LLC SWOT Analysis
Table 17. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product and Services
Table 18. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Major Business
Table 21. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Merck & Co Inc SWOT Analysis
Table 23. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product and Services
Table 24. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AG End-Stage Renal Disease (ESRD) Drugs Major Business
Table 27. Novartis AG End-Stage Renal Disease (ESRD) Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Novartis AG SWOT Analysis
Table 29. Novartis AG End-Stage Renal Disease (ESRD) Drugs Product and Services
Table 30. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. VESSL Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 32. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Major Business
Table 33. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Total Revenue (USD Million) (2018-2019)
Table 34. VESSL Therapeutics Ltd SWOT Analysis
Table 35. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product and Services
Table 36. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global End-Stage Renal Disease (ESRD) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 40. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Regions (2015-2020)
Table 41. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 42. North America End-Stage Renal Disease (ESRD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 43. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries (2015-2020)
Table 44. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 45. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries (2015-2020)
Table 46. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries (2015-2020)
Table 48. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 52. South America End-Stage Renal Disease (ESRD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 53. South America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries (2015-2020)
Table 54. South America End-Stage Renal Disease (ESRD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 55. South America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries (2015-2020)
Table 60. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 61. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2015-2020)
Table 62. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2015-2020) (USD Million)
Table 63. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2015-2020)
Table 64. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 65. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2015-2020)
Table 66. Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Regions (2021-2025)
Table 68. Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Type (2021-2025)
Table 70. Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2021-2025)
Table 71. Global End-Stage Renal Disease (ESRD) Drugs Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Drugs Picture
Figure 2. Global Sales Market Share of End-Stage Renal Disease (ESRD) Drugs by Type in 2019
Figure 3. Calcium Succinate Picture
Figure 4. Mk-3866 Picture
Figure 5. Pacritinib Picture
Figure 6. Sanguinate Picture
Figure 7. Tesidolumab Picture
Figure 8. Others Picture
Figure 9. End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. ICU Picture
Figure 13. Others Picture
Figure 14. Global End-Stage Renal Disease (ESRD) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey End-Stage Renal Disease (ESRD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturer in 2019
Figure 35. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 End-Stage Renal Disease (ESRD) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 End-Stage Renal Disease (ESRD) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions (2015-2020)
Figure 42. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions in 2018
Figure 43. North America End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
Figure 44. Europe End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
Figure 46. South America End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020)
Figure 48. North America End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries (2015-2020)
Figure 50. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries in 2018
Figure 51. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries in 2018
Figure 53. United States End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries in 2019
Figure 59. Germany End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Regions 2019
Figure 66. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions 2019
Figure 67. China End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries in 2019
Figure 74. South America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries in 2019
Figure 75. Brazil End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global End-Stage Renal Disease (ESRD) Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global End-Stage Renal Disease (ESRD) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales End-Stage Renal Disease (ESRD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
末期腎臓病治療の世界市場 2020年 Market Overview The global End-Stage Kidney Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The End-Stage …- メニエール病治療薬の世界市場 2020年 Market Overview The global Meniere Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere Disease Drugs m…
- 腎細胞癌治療薬の世界市場 2020年 Market Overview The global Renal Cell Cacinoma Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Renal Cell Cacinoma…
- 感染症治療薬の世界市場 2020年 Market Overview The global Infectious Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Infectious Disease D…
- パーキンソン病（PD）治療薬の世界市場 2020年 Market Overview The global Parkinson's Disease (PD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Parkinson's Di…